Sin1/MAPKAP1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-56482
Key Product Details
Species Reactivity
Human, Mouse, Rat, Avian, Bovine, Canine, Chicken, Zebrafish
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
A portion of amino acids 85-102 (NTAQRLERLRKERQNQIK) of human Mip1 was used as the immunogen.
Specificity
There are multiple isoforms of this protein, ranging from approximately 310 amino acids to approximately 522 amino acids. Isoform distribution varies with tissue type.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Sin1/MAPKAP1 Antibody
Western Blot: Sin1/MAPKAP1 Antibody [NB100-56482]
Western Blot: Sin1/MAPKAP1 Antibody [NB100-56482] - Analysis of Mip1 in human heart lysate in the 1) absence and 2) presence of immunizing peptide and in human skeletal muscle lysate in the 3) absence and 4) presence of immunizing peptide using this antibody. 5 ug/ml.Applications for Sin1/MAPKAP1 Antibody
Application
Recommended Usage
Western Blot
0.5-2 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS containing 0.2% gelatin
Preservative
0.05% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Sin1/MAPKAP1
Long Name
Mitogen-Activated Protein Kinase Associated Protein 1
Alternate Names
JC310, MAPKAP1, MIP1
Gene Symbol
MAPKAP1
UniProt
Additional Sin1/MAPKAP1 Products
Product Documents for Sin1/MAPKAP1 Antibody
Product Specific Notices for Sin1/MAPKAP1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...